Immunogenic peptides of influenza virus subtype N1 neuraminidase identify a T-cell determinant used in class II major histocompatibility complex-restricted responses to infectious virus
- PMID: 1898970
- PMCID: PMC239806
- DOI: 10.1128/JVI.65.2.672-676.1991
Immunogenic peptides of influenza virus subtype N1 neuraminidase identify a T-cell determinant used in class II major histocompatibility complex-restricted responses to infectious virus
Abstract
Six nonoverlapping peptides of the neuraminidase (NA) glycoprotein of influenza virus A/Puerto Rico/8/34 (H1N1) (PR8 virus) were found to be immunogenic for proliferating T cells when injected into BALB/c mice in Freund adjuvant. T cells elicited by peptide immunization could recognize PR8 virus in vitro. However, only one of these peptides, corresponding to residues 79 to 93 of NA (NA 79-93), was able to restimulate T cells of mice immunized with infectious virus. T cells that recognized this peptide were uniformly I-Ed restricted, yet infectious influenza virus was required for responses. NA 79-93-specific T-hybridoma clones raised by immunization either with whole virus or with the synthetic peptide alone each responded to replicative virus and not to UV-inactivated virions. These data suggest that the NA 79-93 T-cell determinant which is commonly presented during an encounter with influenza virus in vivo is processed preferentially from NA synthesized within antigen-presenting cells.
Similar articles
-
Identification of overlapping class I and class II H-2d-restricted T cell determinants of influenza virus N1 neuraminidase that require infectious virus for presentation.Virology. 1994 May 15;201(1):86-94. doi: 10.1006/viro.1994.1268. Virology. 1994. PMID: 7513927
-
Class I H-2d-restricted cytotoxic T lymphocytes recognize the neuraminidase glycoprotein of influenza virus subtype N1.J Virol. 1990 Mar;64(3):1028-32. doi: 10.1128/JVI.64.3.1028-1032.1990. J Virol. 1990. PMID: 2304137 Free PMC article.
-
Class II major histocompatibility complex-restricted T cells specific for a virion structural protein that do not recognize exogenous influenza virus. Evidence that presentation of labile T cell determinants is favored by endogenous antigen synthesis.J Exp Med. 1989 Mar 1;169(3):921-31. doi: 10.1084/jem.169.3.921. J Exp Med. 1989. PMID: 2784481 Free PMC article.
-
Influenza virus infection elicits class II major histocompatibility complex-restricted T cells specific for an epitope identified in the NS1 non-structural protein.J Gen Virol. 1992 Jun;73 ( Pt 6):1339-43. doi: 10.1099/0022-1317-73-6-1339. J Gen Virol. 1992. PMID: 1376767
-
Identification of eight determinants in the hemagglutinin molecule of influenza virus A/PR/8/34 (H1N1) which are recognized by class II-restricted T cells from BALB/c mice.J Virol. 1991 Jan;65(1):364-72. doi: 10.1128/JVI.65.1.364-372.1991. J Virol. 1991. PMID: 1702160 Free PMC article.
Cited by
-
Optimizing a linear 'Doggybone' DNA vaccine for influenza virus through the incorporation of DNA targeting sequences and neuraminidase antigen.Discov Immunol. 2024 Jan 3;3(1):kyad030. doi: 10.1093/discim/kyad030. eCollection 2024. Discov Immunol. 2024. PMID: 38567290 Free PMC article.
-
Universal Influenza Vaccines: Progress in Achieving Broad Cross-Protection In Vivo.Am J Epidemiol. 2018 Dec 1;187(12):2603-2614. doi: 10.1093/aje/kwy145. Am J Epidemiol. 2018. PMID: 30084906 Free PMC article. Review.
-
NAction! How Can Neuraminidase-Based Immunity Contribute to Better Influenza Virus Vaccines?mBio. 2018 Apr 3;9(2):e02332-17. doi: 10.1128/mBio.02332-17. mBio. 2018. PMID: 29615508 Free PMC article. Review.
-
Neuraminidase delivered as an APC-targeted DNA vaccine induces protective antibodies against influenza.Mol Ther. 2023 Jul 5;31(7):2188-2205. doi: 10.1016/j.ymthe.2023.03.012. Epub 2023 Mar 16. Mol Ther. 2023. PMID: 36926694 Free PMC article.
-
Beyond the classical: influenza virus and the elucidation of alternative MHC class II-restricted antigen processing pathways.Immunol Res. 2011 Dec;51(2-3):237-48. doi: 10.1007/s12026-011-8257-3. Immunol Res. 2011. PMID: 22101673 Review.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources